SMTI
Sanara MedTech Inc. Common Stock
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Sanara MedTech (SMTI) Stock: Buy, Sell, or Hold?
$32.35
-0.19 (-0.58%)
▼
5d:
+2.54%
30d:
-7.81%
90d:
-4.85%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (85%)
Quality Score
64/100
Position
SLIGHTLY LOW
30-Day Fair Range
$32.00 – $34.53
Position: SLIGHTLY LOW
Forward P/E & Valuation
59.9x
STRETCHED
vs 44.6x historical avg
Wall Street Target
$35.00
+8.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$29.05 / $33.32
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: SMTI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Get Alerted When SMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SMTI is currently trading at $32.35, which is considered slightly low relative to its 30-day fair value range of $32.00 to $34.53. From a valuation perspective, the stock is trading at a premium (Forward PE: 59.9) compared to its historical average (44.6). At these levels, the market is pricing in 10.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SMTI is in a strong uptrend. The price is approaching resistance at $33.32. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SMTI is in a strong uptrend. The price is approaching resistance at $33.32. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$32.00 -
$34.53
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.8%
Trading Range & Key Levels
30-Day Trading Range
$32.00 -
$34.53
Current vs Trading Range
SLIGHTLY LOW
Support Level
$29.05
Resistance Level
$33.32
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (73/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($35.00)
- NEUTRAL: Trading at premium valuation - market expects 10.4% growth which is achievable
- BULLISH: Bottoming setup score 73/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
59.91
Wall Street Target
$35.00
(+8.2%)
Revenue Growth (YoY)
9.0%
Profit Margin
-29.1%
Valuation Premium vs History
+10.4% premium
PE vs Historical
59.9 vs 44.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.4%
(market-implied from PE analysis)
1-Year Target
$35.71
(+10%)
2-Year Target
$39.43
(+22%)
3-Year Target
$43.53
(+35%)
3-Yr Target (if PE normalizes)
(PE: 60→45)
PE COMPRESSION
$32.41
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 59.9, Growth: 170.0%)
$109.18
(+238%)
Base:
(SPY PE: 19.9, Growth: 170.0%)
$36.19
(+12%)
Bear:
(PE: 16.9, Growth: 170.0%)
$30.77
(-5%)
Share SMTI Analysis
Share this live SMTI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SMTI)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Vanguard's 10% ownership of $SMTI, as reported in the latest 13F filing, has generated bullish sentiment among traders on StockTwits.
Key Retail Themes:
Vanguard ownership
Institutional interest
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:27 PM ET
Data refreshes hourly during market hours. Next update: 7:27 PM
Data refreshes hourly during market hours. Next update: 7:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 39 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 36 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 46 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SMTI Research Pages
